MedPath

Prevalence of Preoperative Dehydration in Major Elective Urologic Surgery and Its Impact on Postoperative Outcome

Terminated
Conditions
Postoperative Nausea and Vomiting
Postoperative Complications
Dehydration
Registration Number
NCT03788070
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

The primary objective of this study is to measure the prevalence of preoperative dehydration in elective major abdominal urologic surgery when we apply our daily standard operation procedures. Secondary objectives are to assess the impact of preoperative dehydration on postoperative outcome. The hypothesis is that preoperative dehydration leads to more postoperative complications.

Detailed Description

The information about the impact of preoperative dehydration on postoperative outcome is conflicting. One of the reported difficulties of the studies in this field is to get adequate power for statistical significance. The incidence of preoperative dehydration in different surgical populations has been reported in about one third of patients. The prevalence in the urologic population is not known.

This is a monocentric observational study with no study intervention. The goal is to consecutively include all patients undergoing major urologic surgery during 365 days who meet the inclusion criteria to assess the prevalence of preoperative dehydration in elective major abdominal urologic surgery when the standard operation procedures of the University Hospital Bern are applied.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
188
Inclusion Criteria
  • >18 years old
  • Major elective urologic surgery i. Prostate surgery ii. Bladder surgery iii. Kidney surgery iv. Various laparotomies / laparoscopies (e.g. retroperitoneal lymphadenectomy)
  • Standard procedure planned
  • Standard perioperative management planned
  • Informed consent
Exclusion Criteria
  • Preoperative iv-fluids
  • Pregnancy (which is a contraindication to this type of surgery per se)
  • Inability to give informed consent (e.g. severe psychiatric disorder, dementia)
  • Inability to complete the Quality of Recovery (QoR) questionnaire
  • Enrolment of the investigator, his/her family members, employees and other dependent persons

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of Dehydration at Induction of AnesthesiaTime point 0: time (estimated between 7am and 4pm on day of surgery) at Induction of Anesthesia for Major Urologic Surgery

Number of dehydrated patients judged by urine specific gravity, osmolality, creatinine, color.

Secondary Outcome Measures
NameTimeMethod
Postoperative Nausea and Vomiting (PONV)6 hours, 24 hours and 48 hours postoperatively

Number of patients with postoperative nausea and/or vomiting at 6, 24 and 48 hours postoperatively.

Gastrointestinal function (flatus/defecation) postoperatively24 hours and 48 hours postoperatively

Time of first flatus or defecation

Complications within hospitalizationwithin hospital stay, expected to be within 2 weeks postoperatively

Number of complications according to a prospective list

Quality of recovery24 hours postoperatively

Changes in Quality of Recovery using the validated 15 items quality of recovery (QoR-15) score : QoR is a patient reported outcome short questionnaire that measure the quality of recovery after surgery and anaesthesia. It incorporates 5 dimensions of health (patient support, comfort, emotions, physical independence, pain). This is a shortened validated version of the QoR 40 including 15 items. QoR-15, with a score range from 0 to 150 (0 worst possible, 150 best possible), is easy to perform. Recently a meta-analysis showed that QoR 15 fulfils requirements for outcome measurement instruments.

Renal function postoperatively6 hours, 24 hours and 48 hours postoperatively

Creatinine 6, 24 and 48 hours postoperatively.

Fluid balancewithin 24 hours postoperatively

Judged by administered and lost fluids intraoperatively and by weight balance on postoperative day (POD) 1.

Trial Locations

Locations (1)

Inselspital University Hospital Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath